S100A10 and hepatocellular carcinoma: The impact of S100A10 or S100A11 downregulation on liver tumor development was further investigated in aged LPTENKO mice spontaneously developing MASLD-driven HCC and in diethylnitrosamine (DEN)-injected mice fed or not with high fat diet.